Rockefeller Capital Management L.P. raised its holdings in shares of Cencora, Inc. (NYSE:COR – Free Report) by 43.0% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 197,430 shares of the company’s stock after acquiring an additional 59,408 shares during the period. Rockefeller Capital Management L.P.’s holdings in Cencora were worth $66,682,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of COR. Nalls Sherbakoff Group LLC bought a new stake in Cencora in the fourth quarter valued at approximately $84,000. Corient Private Wealth LLC grew its holdings in shares of Cencora by 6.0% in the fourth quarter. Corient Private Wealth LLC now owns 45,818 shares of the company’s stock worth $15,481,000 after purchasing an additional 2,598 shares during the last quarter. Gunpowder Capital Management LLC dba Oliver Wealth Management bought a new position in shares of Cencora in the fourth quarter worth approximately $78,000. Rehmann Capital Advisory Group increased its stake in shares of Cencora by 10.6% in the fourth quarter. Rehmann Capital Advisory Group now owns 2,098 shares of the company’s stock worth $710,000 after buying an additional 201 shares during the period. Finally, SHP Wealth Management bought a new stake in Cencora during the 4th quarter valued at $64,000. Institutional investors own 97.52% of the company’s stock.
Wall Street Analyst Weigh In
Several brokerages have weighed in on COR. Leerink Partners reissued an “outperform” rating on shares of Cencora in a research report on Tuesday, March 17th. Citigroup decreased their price objective on shares of Cencora from $405.00 to $355.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Robert W. Baird lowered their price objective on shares of Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a research note on Thursday, May 7th. Wells Fargo & Company dropped their target price on shares of Cencora from $429.00 to $331.00 and set an “overweight” rating for the company in a report on Monday, May 11th. Finally, William Blair began coverage on Cencora in a report on Tuesday, April 28th. They set a “market perform” rating on the stock. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $374.00.
Cencora Stock Up 0.1%
Shares of NYSE COR opened at $271.99 on Friday. The firm has a fifty day simple moving average of $284.59 and a two-hundred day simple moving average of $324.35. Cencora, Inc. has a 12 month low of $244.82 and a 12 month high of $377.54. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. The firm has a market capitalization of $52.92 billion, a PE ratio of 20.86, a price-to-earnings-growth ratio of 1.47 and a beta of 0.59.
Cencora (NYSE:COR – Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The company had revenue of $78.36 billion for the quarter, compared to analysts’ expectations of $81.09 billion. During the same quarter in the prior year, the firm earned $4.42 EPS. Cencora’s quarterly revenue was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Equities analysts expect that Cencora, Inc. will post 17.79 earnings per share for the current year.
Cencora declared that its Board of Directors has approved a stock repurchase plan on Thursday, May 21st that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to reacquire up to 3.9% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s management believes its stock is undervalued.
Cencora Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were issued a dividend of $0.60 per share. The ex-dividend date was Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.9%. Cencora’s dividend payout ratio is 18.40%.
Cencora Profile
Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.
Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.
Further Reading
- Five stocks we like better than Cencora
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Want to see what other hedge funds are holding COR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cencora, Inc. (NYSE:COR – Free Report).
Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.
